Catalog Number PAJR060502B |
Device Problem
Complete Blockage (1094)
|
Patient Problem
Stenosis (2263)
|
Event Date 05/17/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
Additional reports submitted: 2017233-2020-00186, 2017233-2020-00185.The date the article was accepted is being used as the date of event.
|
|
Event Description
|
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states some patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.4 was treated with an atrium and a gore® viabahn® endoprosthesis with propaten bioactive surface.This patient exhibited rebleeding angiomyolipoma and 80% in-stent restenosis sir grade c.
|
|
Event Description
|
The following information was reported to gore: in an article titled technical considerations and clinical outcomes in the endovascular management of celiac arterial aneurysms it states some patients who underwent treatment of celiac artery aneurysms who were treated with either gore® viabahn® endoprosthesis with propaten bioactive surface or gore® viabahn® vbx balloon expandable endoprosthesis had device related post-procedural complications: patient no.4 was treated with an atrium and a gore® viabahn® endoprosthesis with propaten bioactive surface.This patient exhibited rebleeding angiomyolipoma and 80% in-stent restenosis sir grade c.Complete stent graft thrombosis with good collateral flow through the gda into the pha was demonstrated on follow-up ct angiogram imaging in patient #4, despite prior angioplasty of the stenosed segment with a drug-coated balloon.
|
|
Search Alerts/Recalls
|